Clindamycin und Benzoylperoxid (D10AF51)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter KKH) aims to conclude discount contracts pursuant to § 130a paragraph 8 SGB V with all suitable pharmaceutical companies for the active substance named under BT-21-Lot (ATC) and, if applicable, restricted to certain dosage forms within the framework of a so-called "open-house procedure." Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the conclusion or accession to a discount contract pursuant to § 130a para. 8 SGB V for the aforementioned active substance. Interested pharmaceutical companies can request participation documents as well as the contract from the given contact address. A prerequisite for concluding a contract is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. A contract will be concluded with every pharmaceutical company that meets the participation requirements. There is no exclusivity. Accession or conclusion of the contract can take place at any time and under the same conditions. Individual contractual…

TENDER BRIEF

TENDER DOCUMENTS